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brane protein can interact with the platelet-derived growth factor receptor b, leading to ligand-independent activation and cell
transformation. For productive interaction, E5 needs to dimerize via a C-terminal pair of cysteines, though a recent study sug-
gested that its truncated transmembrane segment can dimerize on its own. To analyze the structure of the full protein in
a membrane environment and elucidate the role of the Cys-Ser-Cys motif, we produced recombinantly the wild-type protein
and four cysteine mutants. Comparison by circular dichroism in detergent micelles and lipid vesicular dispersion and by NMR
in trifluoroethanol demonstrates that the absence of one or both cysteines does not influence the highly a-helical secondary
structure, nor does it impair the ability of E5 to dimerize, observations that are further supported by sodium dodecylsulfate poly-
acrylamide gel electrophoresis. We also observed assemblies of higher order. Oriented circular dichroism in lipid bilayers shows
that E5 is aligned as a transmembrane helix with a slight tilt angle, and that this membrane alignment is also independent of any
cysteines. We conclude that the Cys-containing motif represents a disordered region of the protein that serves as an extra cova-
lent connection for stabilization.INTRODUCTIONSignaling cascades are usually triggered by extracellular
ligands that bind to a receptor. Transmembrane tyrosine-
kinase receptors are generally assumed to dimerize in this
process and undergo autophosphorylation (1–5). A notable
exception, where signaling is induced without the action
of any ligand is the interaction of the oncoprotein E5 from
bovine papillomavirus with the platelet-derived growth
factor receptor b (PDGFR), which transforms epithelial
cells and fibroblasts (6,7). The short E5 protein is itself
present as a dimer in the membrane, assembled by two
disulfide bridges and possible hydrophobic contacts (8,9).
Here, we have investigated the role of these putative dimer-
ization motifs within E5 from a structural point of view, to
better understand the basis of its dimerization and interac-
tion with PDGFR.
Papillomaviruses commonly cause hyperproliferating
epithelial lesions and warts, and some of them also have
transforming activity, e.g., cervical carcinomas can result
from infection with human papillomavirus type 16 (10).
Bovine papillomavirus type 1 (BPV) causes formation of
fibropapillomas in infected cattle and sarcoids in horses.
The primary transforming activity of BPV depends on the
viral protein E5, a hydrophobic 44-amino-acid membrane
protein, which has been found to be sufficient to transform
rodent and human fibroblasts in tissue culture (11). The
main target of E5 is the receptor tyrosine kinase PDGFR
(6,12), but interactions with the epidermal growth factorSubmitted November 18, 2009, and accepted for publication June 21, 2010.
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have also been reported (13–16).
Several mutagenesis studies have shown that the two
cysteines in the C-terminal luminal Cys37-Ser38-Cys39
(CSC) motif of E5 are important for induction of total
DNA synthesis, host-cell transformation, and PDGFR
binding (17–21). Double mutation of the two cysteines
completely abolished the transforming activity of E5 and
interfered with receptor interaction. The location of the
cysteines appeared to be less important and compatible
with a nonhelical conformation, as it was possible to move
them from their original positions 37 and 39 to positions 34
and 42 or 36 and 40 and retain function, although when
they were moved to positions 35 and 41 or 33 and 43, activa-
tionwas lost (19). Furthermore, single-cysteinemutantswere
still able to transform cells and enhance DNA synthesis,
albeit with decreased intensity (18,20). In conclusion, it
was postulated that the cysteines are needed for dimerization
of E5 before its interaction with PDGFR. In line with these
observations, the addition of an extra leucine zipper dimer-
ization motif to the C-terminus of E5 could partially over-
come the destabilizing effect of a double-negative cysteine
mutation (22). A study on the truncated transmembrane
segment of E5, on the other hand, revealed that the hydro-
phobic helical part of the protein is able to dimerize on its
own in vitro (9). Furthermore, recent results demonstrate
that a segment lacking the luminal part of E5 specifically acti-
vates the PDGFR in vivo (23).
Despite extensive investigations in the past decades and
the importance of E5 in virus-induced transformation, no
high-resolution molecular structure of E5 is available.doi: 10.1016/j.bpj.2010.06.073
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spectroscopy study where synthetic E5 was shown to assume
an a-helical secondary structure and a transmembrane orien-
tation (8). Therefore, the role of the cysteines, which had
been shown to be apparently essential for the transforming
function of E5, needs to be reinvestigated. The conforma-
tional constraints imposed on the protein by one or more
disulfide bridges are of particular interest, as there are
numerous open questions concerning the secondary structure
and bridging geometry in the CSC motif. For example,
it might be expected that an a-helical fold would not support
the formation of both intermolecular bridges at the same time
for steric reasons, whereas a parallel or antiparallel b-strand
would be compatible with this sequence. However, to our
knowledge, there has been no discussion of these conforma-
tional aspects in the literature, nor has there been any attempt
to distinguish experimentally between a parallel and
a crossed-over arrangement of the two bridges.
To address these structural questions, we have designed
several cysteine mutants of E5 (Fig. 1). Of these, the
E5-CSC protein corresponds to the wild-type sequence,
which can form two intermolecular disulfide bonds, whereas
the E5-ASC, -CSA, and -ACAmutants can only form a single
bridge, andE5-ASA is unable to undergo any covalent dimer-
ization at all. Using circular dichroism (CD), oriented CD
(OCD), and nuclear magnetic resonance (NMR) to compare
the corresponding secondary structures and oligomerization
behaviors in various membranous environments, we were
thus able to address the conformation of the full E5 protein,
with special attention to the impact of the disulfide bridges.EXPERIMENTAL PROCEDURES
Construction of E5-CSC, E5-ASC, E5-CSA,
E5-ACA, and E5-ASA
The E5 wild-type gene was synthesized and cloned into a pUC19 vector.
The gene was recloned into a pMMHb vector (gift of Peter Kim, Howard
Hughes Medical Institute, Chevy Chase, MD), which added an N-terminal
trp-DLE-sequence (24) to direct the E5-trp-DLE-fusion protein into inclu-
sion bodies. It also provided a His9-tag for affinity chromatography, and
adjacent Asp and Gly residues for cleavage with hydroxylamine, which
added an extra Gly at the N-terminus of the native E5 sequence.FIGURE 1 Nomenclature and sequences of the native E5 (E5-CSC) and
the four cysteine mutants used in our study. The gray box represents
the putative transmembrane segment between Leu7 and Leu29. At the
N-terminus, there is an additional glycine due to hydroxylamine cleavage.
The amino acid substitutions between positions 37 and 39 of the different
E5-mutants are highlighted.The mutants E5-ASA, E5-ACA, E5-CSA, and E5-ASC (Fig. 1) were gener-
ated using the QuickChange Site-Directed Mutagenesis Kit (Stratagene/
Agilent Technologies, Waldbronn, Germany). All sequences were verified
by DNA sequencing. The primer composition can be found in the Materials
and Methods section in the Supporting Material.Expression and purification of the E5 constructs
The plasmids were transfected into Escherichia coli strain BL21(DE3) or
BL21(DE3) pLys (Novagen/Merck Chemicals, Darmstadt, Germany), and
cells were grown to an optical density (OD600) of 0.6–0.8 in LB medium
(standard composition) supplemented with 100 mg/ml ampicillin. In addi-
tion, 20 mg/ml chloramphenicol was added if expressed in E. coli BL21
(DE3) pLysS. Expression was induced by addition of 0.2 mM isopropyl-
b-D-thiogalactopyranoside, and cells were harvested after 6 h. For
uniformly 15N-labeled proteins, the LB medium was replaced by M9
minimal medium supplemented with 0.5 g/L of 15(NH4)2SO4.
The cell pellet was lysed by sonication in 50 mM Tris-HCl, pH 8, 15%
glycerol (v/v), 50 mg/ml lysozyme, and 1 mM NaN3 and centrifuged
at 46,000  g for 1 h. The cell debris was resuspended and sonicated in
50 mM Tris-HCl, pH 8, 1% deoxycholic acid (w/v), 1% IGEPAL-CA
630 (Sigma Aldrich, Hamburg, Germany) (v/v), 1 mM NaN3. After centri-
fugation (56,000  g, 0.5 h), the resulting pellet was resuspended in 6 M
guanidinium-HCl and sonicated again. Ten volumes of water were added
to the suspension, and the insoluble material was collected by centrifuga-
tion at 30,000  g for 1 h.
For cleavage of the trp-DLE-His9 tag, the pellet was resuspended in 6 M
guanidinium HCl, 2 M hydroxylamine HCl, and 4.5 M LiOH, pH 9, and
incubated for at least 6 h at 45C under stirring. The digest was acidified
with formic acid to pH 3 and filtered (0.22 mm). The products of the hydrox-
ylamine cleavage were separated by high-performance liquid chromatog-
raphy (HPLC) using a semipreparative (250  10 mm) reverse-phase C18
polymer column (Grace Silica, Du¨ren, Germany). A focused gradient based
on water/acetonitrile/i-propanol or 2-propanol solvent systems was em-
ployed. The identity and purity of the collected fractions were analyzed by
sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE)
(see Materials and Methods in the Supporting Material) and matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (Autoflex III,
Bruker, Billerica, MA).CD and OCD sample preparation
To reconstitute the E5 protein in detergentmicelles or lipids for CDmeasure-
ments, an appropriate amount of zwitterionic detergent or lipidwas dissolved
in pure 2,2,2-trifluoroethanol (TFE), whereas charged detergents like SDS
were dissolved in TFE/water (50/50, v/v). 1-myristoyl-2-hydroxy-sn-glyc-
ero-3-phosphocholine (LMPC), 1-palmitoyl-2-hydroxy-sn-glycero-3-phos-
phocholine (LPPC), and dodecylphosphocholine (DPC) were used as
zwitterionic detergents; SDS and 1-palmitoyl-2-hydroxy-sn-glycero-3-
(phospho-rac-(1-glycerol)) (LPPG) were used as anionic detergents; and
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) was used as a lipid.
An aliquot of this detergent (or lipid) stock solution containing 2–30 mM
detergent (or lipid) was added to an aliquot of the E5 stock solution in TFE
(5–10 mmol protein). The solvents were evaporated by a stream of nitrogen
and the samples were then lyophilized. To prevent oligomerization, samples
were rehydrated with 200 ml acidified water (pH 3.3) and sonicated. The pH
was adjusted to neutral with phosphate buffer. Lipidic samples of various
protein/lipid ratios were incubated in an ultrasonic bath for 15 min at
maximum power to generate small unilamellar vesicles, which were kept
in the liquid crystalline state (~30C) until measurement.
CD spectroscopy
CD spectra of E5-CSC and the mutants were recorded in aqueous micelle
solutions and vesicle suspensions as previously described (25). SpectraBiophysical Journal 99(6) 1764–1772
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above the phase-transition temperature of the corresponding lipids, using
a water-thermostatted cell holder. Final CD spectra were averaged from
three scans at a rate of 10 nm min1, 8-s response time, and 1-nm band-
width, and smoothed by the adaptive smoothing method, which is part of
Spectra Analysis software (Jasco, Easton, MD). Secondary-structure anal-
ysis was performed using the CONTIN-LL (26,27) and CDSSTR (28)
algorithms provided by the DICHROWEB server (28–30). The quality of
the fit between the experimental and back-calculated spectra corresponding
to the derived secondary structure was assessed from the normalized-root-
mean-square deviation (NRMSD), with a value of <0.1 considered a good
fit (30). For calculating the mean residue ellipticities used for secondary-
structure estimation, the concentration of the E5 protein solutions was
determined based on the absorbance of the protein at 280 nm (31). For
secondary-structure deconvolution, we used the average concentration of
E5, determined in all detergents used because the reconstitution efficiency,
and thus the concentration, varied slightly from sample to sample.FIGURE 2 (A) Chromatographic analysis of E5-CSC and the cysteine-
free mutant E5-ASA. In the HPLC trace, the wild-type protein eluted as
two distinct fractions dominated by monomers (retention time of 12 min)
or dimers (retention time of 18 min). The molecules in the dimer fraction
could be converted into momomers by reduction of the disulfide bridges
with TCEP. E5-ASA consisted mostly of monomers, as expected. (B and
C) SDS-PAGE of the dimeric (B) and monomeric (C) fractions under nonre-
ducing conditions. Lanes represent a molecular weight marker (a), E5-CSCOCD spectroscopy
Macroscopically oriented CD samples were prepared from the E5 vesicle
suspensions used for the CD measurements by depositing a 50- to 100-ml
aliquot of the sample (containing 0.2 mg lipid) on a quartz glass plate
with a 20-mm diameter. In this way, we could generate thin lipid bilayer
samples to avoid possible spectral artifacts caused by, e.g., linear dichroism
(32). The water of the vesicle suspension was allowed to evaporate in a
gentle stream of air until the sample appeared dry (a circular spot
of ~12-mm diameter). Samples were subsequently hydrated for 15 h at
30C in a sample cell for OCD measurements manufactured in-house as
previously described (33). A small volume of saturated K2SO4 salt solution
(300–500 ml) was placed in the bottom of the cell to maintain 97%
humidity. To reduce possible spectral artifacts caused by the linear
dichroism arising from imperfections in the sample, strain in the quartz
glass windows, or imperfect alignment of the windows (34), OCD spectra
were recorded every 45.0 of rotation of the cell as an average of three scans
using the same data acquisition parameters as in the normal CD measure-
ments above (35). The eight spectra were subsequently averaged, and
background spectra of lipid bilayers without protein were subtracted.(b), E5-ASC (c), E5-CSA (d), E5-ACA (e), and E5-ASA (f).NMR spectroscopy
For NMR experiments, 1 mg of protein powder was dissolved in TFE
and sonicated for at least 5 min. Undissolved particles were removed by
centrifugation to get a clear solution and D2O (20% (v/v)) was added.
For chemical-shift calibration, and to compare relative signal intensities,
0.2 mM 2,2-dimethyl-2-silpentane-5-sulfonic acid was added. 15N-HSQC
spectra were acquired at 37C on a Bruker Avance II 600 spectrometer
equipped with a broadband triple resonance probe, with 128 scans/incre-
ment and a total of 128 increments in the indirect dimension. Data were
processed and analyzed with TOPSPIN software (Bruker-BioSpin, Rhein-
stetten, Germany).RESULTS
Production of the wild-type E5 protein and its four
cysteine mutants
E5 and its mutants (Fig. 1) were expressed in E. coli as
fusion proteins to a trp-DLE sequence, which directs the
protein into inclusion bodies. As these turned out to contain
virtually pure fusion protein, no further affinity chromatog-
raphy step was required. The trp-DLE-His9 tag was cleaved
off with hydroxylamine, which added a Gly to theBiophysical Journal 99(6) 1764–1772N-terminus of all constructs. HPLC was used to separate
the mixture of protein monomers and dimers, as illustrated
in Fig. 2 A for representative mutants and redox conditions.
Matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry analysis of the collected fractions
showed that the peak at the lower retention time contained
monomeric E5 (5.2 kDa), whereas the other fraction at
higher retention time was primarily composed of dimers
(10.4 kDa). This latter fraction could be converted to the
monomer by addition of the reducing agent tris-(2-carboxy-
ethyl)-phosphine (TCEP). The cysteine-free E5-ASA
mutant eluted as a single fraction at the earlier retention
time, corroborating that this peak corresponds to the mono-
mer (Fig. 2 A).
SDS-PAGE analysis (under reducing and nonreducing
conditions) showed one band, at apparent 14 kDa, for the
dimer fractions (Fig. 2 B) and two bands, at apparent
11 kDa and 14 kDa, for the monomer fractions (Fig. 2 C).
These bands correspond to monomeric and dimeric E5,
respectively, as this hydrophobic protein is known to migrate
at higher apparent masses on SDS-PAGE. Despite the fact
Role of Cysteines in Dimerization of E5 1767that E5-ASA is not able to form a covalent dimer, this
construct also showed a dimer band. Further bands at higher
molecular masses were also observed, indicating the pres-
ence of higher oligomers under all SDS-PAGE conditions.
Only the HPLC purified dimer fractions of the Cys-con-
taining E5 proteins were used for further structural analysis.
For comparison in the case of E5-ASA, the fraction eluting
at the retention time of the monomer was used.FIGURE 3 CD spectra of E5-CSC and mutants in detergent micelles and
liposomes. (A) Aqueous solution of 10 mM LPPC micelles at 20C,
showing a predominantly a-helical conformation of the proteins. (Inset)
Measured CD spectra normalized to the maximum ellipticity at 194 nm.
(B) DMPC/LMPC vesicle suspensions (pH 3) with a protein/lipid ratio of
1:300 (mol/mol) measured above the lipid phase transition at 30C.CD spectroscopy
In pure TFE, all E5 variants showed a pronounced a-helical
conformation (Fig. S1 A in the Supporting Material).
The highly congruent CD spectra indicated no differences
in helicity between the wild-type protein and any of its
mutants. Estimation of the helical fraction from the observed
mean residue molar ellipticity (MRE) at 220 nm (36,37)
resulted in an a-helical content of ~70%, which corresponds
to ~31 residues (out of 45 total) adopting this conformation.
A more relevant membranelike environment was gener-
ated by reconstitution in zwitterionic (LMPC, LPPC, and
DPC) and anionic detergents (SDS and LPPG), and in
uncharged liposomes (DMPC/LMPC). Fig. 3 A depicts
representative CD spectra of E5 and its mutants in LPPC
micelles. Again, all variants showed a typical a-helical
spectrum, but the MRE values decreased by ~10–15%
compared to TFE values. The same picture was obtained
also in DPC, LMPC, LPPG, and SDS (Fig. S1, B–E). It is
interesting that monomeric E5-ASA showed the same
secondary structure as dimeric E5 wild-type and single-
cysteine mutants. Addition of TCEP to reduce the disulfide
bridge(s) had no effect on the secondary structure of either
the wild-type E5 protein or its mutants (Fig. S2), in agree-
ment with the results for E5-ASA.
In zwitterionic DMPC/LMPC liposomes, the negative
signal intensity at 222 nm was increased relative to that at
208 nm (Fig. 3 B). This is interesting, as the ratio between
the minima has been interpreted previously as reflecting
the coiled-coil structure of two parallel oriented helices
(38), though this interpretation is not generally accepted
and secondary-structure prediction programs (see below)
do not take it into account.
Secondary-structure estimation with the algorithm
CONTIN-LL (26,27) or the CDSSTR algorithm (Table S1
and Table S2) showed that, within error, all mutants have
the same amount of a-helical secondary structure as the
wild-type. The overall helicity of the proteins ranged
from ~75% in LPPC and DPC to ~82% in LMPC, LPPG,
and SDS micelles and DMPC/LMPC liposomes. The slight
differencesmost likely result from small errors in the concen-
tration determination (Materials andMethods in the Support-
ing Material). In general, CONTIN-LL yielded a ~25%
higher total helical fraction (regular and distorted helices)
compared to single-wavelength analysis at 220 nm (fH in
Table S1). However, the latter values nicely matched theprediction of CONTIN-LL for the regular helix fractions,
aR, which—depending on the detergent or lipid—were in
the range 51–56%.Influence of pH and temperature
We noticed that the pH used during reconstitution of the
protein into detergents or lipids had a dramatic influence
on the shape and intensity of the CD spectrum. The highest
apparent secondary-structure contents were obtained when
the proteins were initially kept under acidic conditions
during reconstitution and the pH adjusted only afterward
to neutral. To maintain well-defined conditions, we dialyzed
the HPLC fraction against pure H2O at neutral pH and
lyophilized afterward. The pH in these samples could be
easily adjusted to the desired value by rehydration with
phosphate buffer or water.
However, samples prepared from these stock solutions at
neutral pH yielded turbid solutions. Fig. 4 shows represen-
tative CD spectra of E5-CSC in DPC micelles reconstituted
under such conditions. These CD spectra at pH 7 were still
reminiscent of a-helices, but the peak at 208 nm was signif-
icantly decreased in intensity, whereas the one at 197 nmBiophysical Journal 99(6) 1764–1772
FIGURE 4 CD spectra showing the pH and temperature dependence of
E5-CSC, acquired in 10 mM DPC micellar solution. By heating to 90C
and cooling back to 20C, the aggregated protein at pH 7 could be converted
into almost the same regular helical structure as the acidified sample main-
tained at pH 3.
1768 Windisch et al.was slightly red-shifted and the crossover point moved from
203 to 206 nm. An estimation of the secondary-structure
content was not possible with any of the available programs.
Not only did the turbidity in these samples suggest protein
aggregation, but in some preparations the intensity at short
wavelengths was severely reduced due to absorption
flattening or differential light-scattering effects, which is
a typical sign of aggregation (39). The corresponding ultra-
violet (UV) spectra exhibit a distinct baseline offset and
strong exponential increase of apparent absorption at shorter
wavelengths due to scattering (Fig. S4). It is interesting that
all samples became clear when the pH was adjusted to
acidic conditions (pH 3), resulting in CD spectra with
a characteristic a-helical lineshape and appropriate
intensities. The UV spectra of the acidified CD samples
showed the artifact-free absorption spectrum of peptide
chromophores with a maximum around 190 nm and
minimal baseline offset.FIGURE 5 OCD spectra of E5-CSC and mutants in oriented lipid bila-
yers of DMPC/LMPC, acquired at 30C and 97% relative humidity. (Inset)
The spectra are normalized to the same intensity (225 nm) to illustrate the
similarity in the lineshapes.
Biophysical Journal 99(6) 1764–1772Aggregation could also be largely reversed if the samples
were heated up to 90C and cooled back to room tempera-
ture. The corresponding spectra of aggregated E5-CSC in
DPC micelles are shown in Fig. 4 (and the same for
E5-ACA and E5-ASA in DPC in Fig. S3). Only relatively
small spectral changes occurred up to 50C, and up to
90C a predominantly helical spectrum was observed. An
unexpected finding was the more intense a-helical spectrum
when the sample was cooled back to 20C. This indicated
disassembly of the aggregates. Disassembly under the
conditions chosen was not complete, however, as the
refolded spectrum does not fully correspond to the a-helical
spectrum obtained at 20C and pH 3.Oriented CD
To characterize the alignment of the different E5 proteins in
the lipid bilayer we used OCD, which is a powerful tool for
the study of a-helical segments of membrane-bound
proteins in their native lipid environment. To discriminate
between a transmembrane orientation and a surface align-
ment of well-folded a-helical segments, the most informa-
tive feature is the presence or absence of a negative band
around 208 nm (25). Each E5 protein was reconstituted at
a protein/lipid ratio of ~1:300 in DMPC/LMPC bilayers
and spread onto the OCD quartz window to give a macro-
scopically oriented membrane sample. To verify that well-
oriented bilayers were formed, solid-state 31P-NMR spectra
were measured from samples prepared in the same way
(Fig. S6 and Materials and Methods in the Supporting
Material).
All E5 variants had a mostly a-helical conformation in
the lipid bilayer (Fig. 5). Despite the standardized protocol
for sample reconstitution, OCD spectra are less reproducible
than CD spectra in solution, probably due to slight differ-
ences in drying the vesicle suspensions. To account for these
potential errors, spectra of two to six separate OCD samples
were averaged for each E5 variant. Normalization to the
intensity at 225 nm (Fig. 5, inset) showed that any remaining
differences mainly occurred below 200 nm, probably
because of residual linear dichroic effects. For preparation
of the E5 wild-type and mutant OCD samples, only small
unilamellar vesicle dispersions were used, because these
are less likely to cause absorption flattening (39). The
representative UV spectra of E5 wild-type, E5-ACA, and
E5-ASA (Fig. S5) are free of absorption flattening and
scattering artifacts. Since all variants possessed a distinct
residual negative intensity of the 208-nm band, a perfectly
upright transmembrane orientation of E5 could be ruled
out. The ratio of the negative band at 208 nm to that at
225 nm, being close to 0.7, could be attributed to one of
two scenarios: 1), the observed spectrum is the sum
of two populations arising from parallel and perpendicularly
aligned helices, or 2), the E5 transmembrane segment
assumes a uniform but slightly tilted alignment in the lipid
FIGURE 6 Superposition of the 1H15N-HSQC
spectra of wild-type E5-CSC (black) and mutants
(red) E5-ASC (A), E5-CSA (B), E5-ACA (C),
and E5-ASA (D) in 80% TFE.
Role of Cysteines in Dimerization of E5 1769bilayer. An argument in favor of the second scenario is the
distinct hydrophobicity of the protein, which favors a
transmembrane alignment. We thus estimated the alignment
of the E5 helix to be tilted by an angle of ~26–30 with
respect to the membrane normal. This angle was calculated
from the helix orientational order parameter, which was
obtained from the CD difference spectra of the protein
aligned in planar oriented bilayers and that in lipid vesicles
(the isotropic case) (40,41).NMR spectroscopy
We tried to reconstitute E5 in DPC or SDS micelles, but
despite a clear appearance of the solution, the resulting
spectra suffered from severe exchange broadening. This
could not be mended by using either low or high peptide
concentrations (a range of 50 mM to 1 mM was tested) or
by changing buffer, sample temperature, or detergent
concentration. On the other hand, the spectrum quality
improved dramatically in 80% TFE at 37C (Fig. 6, A–D)
and the resonances were well dispersed. TFE is known torealize internal hydrogen bond potential and may favor
additional structuring that is not stably present in other
solvents. We do not think, however, that this is detrimental
to our aim, because we sought to understand whether the
C-terminal part is capable at all of forming secondary struc-
ture, and whether the disulfide bridges influence this. Our
CD measurements show that the helicity of E5 is increased
in TFE, but we are strongly convinced that the organic
solvent at best induces secondary structure (which in more
nativelike conditions is eventually less stable) but does not
impose structuring that opposes the native conformation.
Superposition of the mutant spectra with the wild-type
demonstrated that the presence and relative position of the
disulfide bond had only minor effects on the overall protein
structure, because the majority of the peaks remained unaf-
fected. Although the observed differences might reflect
some subtle changes in the arrangement of the C-terminal
part of E5, it is more likely that they are attributable to
the local effects arising from the substitution of the cyste-
ines, in accordance with the results obtained from CD and
OCD. Thus, the overall similarity of the NMR spectraBiophysical Journal 99(6) 1764–1772
1770 Windisch et al.confirmed that the three-dimensional structure of E5
remains unaffected by the presence of two, one, or no disul-
fide bridges.FIGURE 7 (A) Proposed model of the membrane-inserted structure of
E5. The gray box represents the putative transmembrane segment that forms
the regular helix fraction (solid outline), which is flanked by distorted
helical regions (dotted outline) that extend beyond the lipid bilayer. The
cysteines are located in the adjacent unstructured stretch near the
C-terminus. (B) Three-dimensional scheme of the E5 dimer in a lipid
bilayer based on the model in A. The regular helix parts are shown as red
and the distorted helical regions as pale red in the cylinders, and the
unstructured parts are shown as black lines. The cysteines are arranged to
allow parallel disulfide bridges between Cys37-Cys37 and Cys39-Cys39.
The sketch was made using POV-Ray (Persistence of Vision Raytracer).DISCUSSION
Dimerization of E5 is considered to be an essential step for
productive interaction with the PDGFR. Early studies had
demonstrated the functional importance of the two
conserved cysteines at position 37 and 39, and it was
commonly assumed that E5 homodimerizes via two inter-
molecular disulfide bridges (17–21). A recent study on the
truncated transmembrane segment, however, reported that
this part of E5 per se is able to dimerize in vitro (9). This
finding is further confirmed by our results, which indicate
that the cysteine-free mutant of E5 forms stable dimers in
SDS-PAGE and shows no structural differences from the
wild-type or the single-cysteine mutants. Given the previous
mutagenesis experiments, we were surprised to find in our
experiments that the presence of the disulfide bridge(s)
had an influence on neither the secondary structure nor the
thermal stability of E5. Both E5-CSC and the single-
cysteine mutants E5-ASC, E5-CSA, and E5-ACA, which
had been designed to examine the influence of the position
of the disulfide bridge, displayed virtually identical struc-
tural features in all CD and NMR experiments. Even the
cysteine-free mutant E5-ASA, which is incapable of cova-
lently dimerizing and had been designed to represent
a monomeric form of E5, was indistinguishable from the
wild-type. OCD in lipid bilayers and NMR analysis in
TFE corroborated the absence of fundamental structural
differences between the various mutants and the wild-type
protein, either in solution or in a proper membrane environ-
ment.
Prediction programs (SOSUI (42) or TMHMM server
(43)) define the region from Leu7 to Leu29 as a transmem-
brane helix with a typical length of 23 residues (Fig. 1).
From an inspection of the E5 sequence, however, the total
hydrophobic region extends from Leu4 to at least Trp32,
with Asn3 being an ideal N-capping residue for a helix.
This extended length fits well with the total a-helical
content estimated by deconvolution of the CD spectra (for
TFE, 31 amino acids; in the comparatively thin DMPC
bilayer, 25 residues). A caveat for these CD-derived values
is, however, that current secondary-structure prediction
programs use a CD reference data set that contains mainly
globular soluble proteins, which may not be fully adequate
for membrane proteins (44). By single-wavelength deconvo-
lution, an a-helical content of ~50–60% (23–27 residues)
can be estimated (fH in Table S1), which would correspond
approximately to the predicted transmembrane part and also
fit to the regular helix fraction, aR. An additional fraction of
~25% (9–11 residues) distorted helix (aD) has emerged
from this analysis, which most reasonably reflects distorted
helical stretches directly adjacent to both ends of the trans-Biophysical Journal 99(6) 1764–1772membrane segment beyond the lipid bilayer (Fig. 7). The
higher a-helicity induced by TFE indeed suggests that the
a-helix can extend beyond the transmembrane part.
In a previous study on the wild-type E5 protein in DMPC
bilayers, an even longer, continuous helix of 39 residues was
postulated, encompassing the CSC motif (8). That model
structure, however, would place the two cysteines (position
37 and 39) onto opposite faces of the helix, which is steri-
cally difficult to reconcile with the formation of two simul-
taneous intermolecular disulfide bridges in a dimer.
Therefore, we interpret our observed values of 50% regular
and up to 80% total helical content in terms of a structural
model in which parts of the extramembranous regions of
E5 do not form a continuous a-helix. The results of our
mutation studies confirm that this is indeed the case, as
the cysteines must lie outside the helical region.
Support for this structural model comes from the results
reported by DiMaio and co-workers. By fusing a leucine
zipper dimerization motif N-terminally to the truncated
(Cys-free) transmembrane fragment of E5, they imposed
Role of Cysteines in Dimerization of E5 1771different arrangements on the monomers within a dimer and
sampled different interfaces in this way (22). Only one of
their fusion proteins was as efficient as the wild-type in
transformation, whereas the activity of the others dropped
considerably. Hence they could show that only one specific
interfacial arrangement leads to functional activity of E5.
In such a particular, fixed dimer arrangement, the cysteines
are obviously not able to simultaneously form a disulfide
bridge to the other monomer if arranged as an a-helix.
Moreover, we found that shifting the position of the cysteine
bridge within the motifs CSA/ACA/ASC (in an a-helix this
would result in a side-chain rotation of ~100) had no influ-
ence on the secondary and tertiary structure of E5, nor on its
interaction with the lipid bilayer. Thus, it is highly likely
that the cysteine-containing part is unstructured. Further-
more, we can conclude that the Cys-containing stretch of
E5 is most likely arranged in a parallel fashion in the dimer,
allowing bridges to form between Cys37-Cys37 and Cys39-
Cys39 (rather than being crossed over between Cys37 and
Cys39), because the E5-ASC and E5-CSA mutants can
dimerize just as readily as the wild-type E5 and do not
show significant differences in the NMR spectra (Fig. 6).
The existence of several different types of dimerization
motifs, namely two covalent disulfide bridges and a putative
hydrophobic leucine zipper (8) in such a small protein is
remarkable. Although we can only speculate in the light
of previous functional studies, it is possible that the cyste-
ines may confer additional stabilization to the dimer within
the cellular environment, or that they may be important for
initiation of folding.
One remarkable observation is that all E5 variants were
prone to aggregation, depending on the sample conditions,
and that acidification or heating above 90C reversed this
self-assembly. Since this tendency was independent of the
presence of any disulfide bonds, the formation of higher
covalent oligomers through the second cysteine bridge can
be ruled out. Such an oligomerization had not been noticed
for the truncated transmembrane part of E5 (9), which ended
with His34 but contained three additional N-terminal and
one C-terminal Lys to increase solubility. Similar pH- and
temperature-dependent effects had been noted in the litera-
ture for designer-made helical peptides. It was shown by
electron microscopy that they form higher-order associates
of coiled coils (45,46). In addition to His34, two acidic resi-
dues, Asp33 and Glu36, are located at the juxta-membrane
C-terminal position. At pH 7.0, ionization of these residues
could lead to a change in the net charge from þ1 (at pH 3)
down to 2 (depending on the protonation state of His).
Moreover, if we assume that this part of the sequence is still
included in the a-helix, the two acidic side chains not only
would be adjacent to one another but would increase the
helix dipole moment considerably at neutral pH. Maybe
this effect prevents proper reconstitution into the detergents
or lipids, as we observed, so that an alternative pathway to
form coiled-coil aggregates becomes energetically morefavorable. Below pH 4, only one positive charge (of the
histidine) remains, which diminishes the helix dipole
moment and eventually allows better interaction with the
membrane.SUPPORTING MATERIAL
Additional materials and methods, additional CD and UV spectra, solid-
state 31P-NMR spectra of oriented samples, and secondary-structure decon-
volution with CONTIN-LL and CDSSTR are available at http://www.
biophysj.org/biophysj/supplemental/S0006-3495(10)00844-1.
The authors thank Dr. Ralf Heinzmann for his help in preparing the scheme
of the E5 structure using the POV-Ray program.REFERENCES
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